You’re probably right. It’s more than likely the cost per dose. Which is also what the $1000 figure represents.
The Vermont independent (Bernie) called on Novo Nordisk to lower the list price of Ozempic to $155 a month or less, in line with what it charges in other countries.
Somehow they can justify selling it for $155 a dose (per month?) in other countries while still making a profit above the overhead and compliance costs.
Tried out GPT4 when it first dropped. Glorified chatbot that has zero agency. I struggle to find an application for it other than summarizing blocks of text.